Press Releases

CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity

Yuvraj — Thu, 04 Jun 2026 09:43:13 +0000

Informa Markets has announced that CPHI Americas will relocate to Miami in 2027, marking a significant step in the event’s ongoing development as a platform for pharmaceutical innovation, outsourcing and strategic partnerships. Scheduled for May 25-26, 2027, at the Miami Convention Center, the move is intended to improve international accessibility, encourage greater executive participation and […]

The post CPHI Americas Relocates to Miami to Strengthen Global Industry Connectivity first appeared on World Pharma Today.

Aragen Achieves Daretabart Commercial-scale GMP Production

Yuvraj — Wed, 03 Jun 2026 11:50:39 +0000

Aragen, a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has announced the successful technology transfer and commercial-scale GMP manufacturing of the first batches of Daretabart, Renaissance Pharma’s lead therapeutic candidate for high-risk neuroblastoma. The milestone was achieved within just nine months, highlighting the efficiency of the collaboration between the two organizations. […]

The post Aragen Achieves Daretabart Commercial-scale GMP Production first appeared on World Pharma Today.

Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe

Yuvraj — Mon, 01 Jun 2026 05:48:10 +0000

Nestlé Health Science and IdB Holding have officially announced a VOWST licensing agreement to develop and commercialize the oral therapy in Europe, subject to approval by the European Medicines Agency (EMA). This collaboration aims to expand European patient access to therapies preventing recurrent Clostridioides difficile infection, a severe gastrointestinal condition with limited management options. Currently […]

The post Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe first appeared on World Pharma Today.

CordenPharma Seals AmbioPharm Deal to Expand Global Network

Yuvraj — Sat, 30 May 2026 08:25:37 +0000

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm Deal strengthens the company’s manufacturing presence in the United States while adding newly integrated production capabilities in Shanghai, China. The move allows CordenPharma to comprehensively support the growing global demand for […]

The post CordenPharma Seals AmbioPharm Deal to Expand Global Network first appeared on World Pharma Today.

Shilpa Biologicals Urges Stronger CDMO Selection Strategy

Yuvraj — Sat, 30 May 2026 07:52:22 +0000

Ahead of BIO San Diego next month, Shilpa Biologicals has called on emerging biotech companies to rethink how they approach CDMO Selection as investment conditions begin to improve across the biopharma sector. Madhav Bhutada, Director of Shilpa Biologicals, said many innovators developing increasingly sophisticated therapies, including bispecific and trispecific antibodies, continue to depend on a […]

The post Shilpa Biologicals Urges Stronger CDMO Selection Strategy first appeared on World Pharma Today.

Chemspec Europe 2026 Draws Global Industry Participation

Yuvraj — Fri, 29 May 2026 11:05:12 +0000

Chemspec Europe returned to Cologne on 6–7 May 2026, bringing together professionals from across the speciality chemicals sector despite ongoing economic and regulatory challenges facing the industry. The event welcomed 4,238 attendees representing 60 nations and featured 454 exhibitors from 28 countries, marking growth compared with the previous edition. Participants represented a broad range of […]

The post Chemspec Europe 2026 Draws Global Industry Participation first appeared on World Pharma Today.

eschbach Unveils Seqonis Intelligent Operations Platform

Yuvraj — Fri, 22 May 2026 10:01:18 +0000

eschbach has renamed its flagship enterprise software platform, Shiftconnector, to Seqonis, marking a new phase in the product’s development after two decades of expansion across pharmaceutical, chemical and process manufacturing industries. The announcement was made during the Pharma Manufacturing World Summit and AVEVA World on May 19, 2026, as the company outlined its long-term strategy […]

The post eschbach Unveils Seqonis Intelligent Operations Platform first appeared on World Pharma Today.

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Yuvraj — Tue, 19 May 2026 05:02:18 +0000

Agilent Technologies and Veeda Lifesciences have announced a strategic collaboration aimed at strengthening regulatory-aligned analytical and bioanalytical workflows for biopharma development as GLP-1 and other advanced therapeutic modalities continue to progress across global pipelines. The partnership will combine Agilent’s analytical workflow development expertise with Veeda’s bioanalytical, clinical research and regulatory capabilities to support biopharma companies […]

The post Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub first appeared on World Pharma Today.

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

Yuvraj — Fri, 15 May 2026 10:50:47 +0000

A long-term development and commercial manufacturing agreement has been signed between Shilpa Medicare Limited and Switzerland-based NXI Therapeutics AG, extending the Indian pharmaceutical company’s role in global biologics and specialty therapeutics manufacturing. The agreement covers comprehensive chemistry, manufacturing and controls development, process scale-up, GMP clinical supply, and commercial manufacturing support for NXI’s immunomodulatory program. The […]

The post Shilpa Medicare, NXI Therapeutics AG Enters Partnership first appeared on World Pharma Today.

Cantex and Headlamp Target MS Depression Using Lumos AI

Yuvraj — Fri, 15 May 2026 09:13:20 +0000

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration aimed at advancing the clinical development of azeliragon for the treatment of severe depression and fatigue in patients with multiple sclerosis (MS). Through the agreement, Cantex and Headlamp will apply Headlamp’s Lumos AI platform to support patient stratification, optimize trial design, and accelerate development activities surrounding […]

The post Cantex and Headlamp Target MS Depression Using Lumos AI first appeared on World Pharma Today.